Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
Identifieur interne : 000521 ( Istex/Curation ); précédent : 000520; suivant : 000522Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
Auteurs : Junbao Yang [États-Unis] ; Eddie James [États-Unis] ; Michelle Roti [États-Unis] ; Laurie Huston [États-Unis] ; John A. Gebe [États-Unis] ; William W. Kwok [États-Unis]Source :
- International Immunology [ 0953-8178 ] ; 2009.
Abstract
Identification of dominant T cell epitopes within newly emerging and re-emerging infectious organisms is valuable in understanding pathogenic immune responses and potential vaccine designs. However, difficulties in obtaining samples from patients or convalescent subjects have hampered research in this direction. We demonstrated a strategy, tetramer-guided epitope mapping, that specific CD4+ T cell epitopes can be identified by using PBMC from subjects that have not been exposed to the infectious organism. Sixteen HLA-DR0401- and 14 HLA-DR0701-restricted epitopes within spike protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) were identified. Among these, spike protein residues 159–171, 166–178, 449–461 and 1083–1097 were identified to contain naturally processed immunodominant epitopes based on strong in vitro T cell responses of PBMC (as assayed by tetramer staining) to intact spike protein stimulation. These immunodominant epitopes were confirmed in vivo in HLA-DR0401 transgenic mice by immunizing with spike protein. Furthermore, the epitope-specific T cells from naive donors secreted IFN-γ and IL-13 upon re-stimulation with corresponding tetramers. Our study demonstrates a strategy to determine potential immunodominant epitopes for emerging infectious pathogens prior to their epidemic circulation.
Url:
DOI: 10.1093/intimm/dxn124
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000521
Links to Exploration step
ISTEX:7A829C7ABFA12E0A0EFA5E81E87A85C9C7F396E7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals</title><author><name sortKey="Yang, Junbao" sort="Yang, Junbao" uniqKey="Yang J" first="Junbao" last="Yang">Junbao Yang</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="James, Eddie" sort="James, Eddie" uniqKey="James E" first="Eddie" last="James">Eddie James</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Roti, Michelle" sort="Roti, Michelle" uniqKey="Roti M" first="Michelle" last="Roti">Michelle Roti</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Huston, Laurie" sort="Huston, Laurie" uniqKey="Huston L" first="Laurie" last="Huston">Laurie Huston</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Gebe, John A" sort="Gebe, John A" uniqKey="Gebe J" first="John A." last="Gebe">John A. Gebe</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Kwok, William W" sort="Kwok, William W" uniqKey="Kwok W" first="William W." last="Kwok">William W. Kwok</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Immunology, University of Washington, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Immunology, University of Washington, Seattle, WA</wicri:regionArea></affiliation><affiliation><mods:affiliation>E-mail: bkwok@benaroyaresearch.org</mods:affiliation><wicri:noCountry code="no comma">E-mail: bkwok@benaroyaresearch.org</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7A829C7ABFA12E0A0EFA5E81E87A85C9C7F396E7</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1093/intimm/dxn124</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-RCRGKT04-R/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000521</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000521</idno><idno type="wicri:Area/Istex/Curation">000521</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals</title><author><name sortKey="Yang, Junbao" sort="Yang, Junbao" uniqKey="Yang J" first="Junbao" last="Yang">Junbao Yang</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="James, Eddie" sort="James, Eddie" uniqKey="James E" first="Eddie" last="James">Eddie James</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Roti, Michelle" sort="Roti, Michelle" uniqKey="Roti M" first="Michelle" last="Roti">Michelle Roti</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Huston, Laurie" sort="Huston, Laurie" uniqKey="Huston L" first="Laurie" last="Huston">Laurie Huston</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Gebe, John A" sort="Gebe, John A" uniqKey="Gebe J" first="John A." last="Gebe">John A. Gebe</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation></author><author><name sortKey="Kwok, William W" sort="Kwok, William W" uniqKey="Kwok W" first="William W." last="Kwok">William W. Kwok</name><affiliation wicri:level="1"><mods:affiliation>Benaroya Research Institute at Virginia Mason, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Benaroya Research Institute at Virginia Mason, Seattle, WA</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Immunology, University of Washington, Seattle, WA, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Immunology, University of Washington, Seattle, WA</wicri:regionArea></affiliation><affiliation><mods:affiliation>E-mail: bkwok@benaroyaresearch.org</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Immunology</title><idno type="eISSN">1460-2377</idno><idno type="ISSN">0953-8178</idno><imprint><publisher>Oxford University Press</publisher><date>2009</date><date type="e-published">2008</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="63">63</biblScope><biblScope unit="page" to="71">71</biblScope></imprint><idno type="ISSN">0953-8178</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0953-8178</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Identification of dominant T cell epitopes within newly emerging and re-emerging infectious organisms is valuable in understanding pathogenic immune responses and potential vaccine designs. However, difficulties in obtaining samples from patients or convalescent subjects have hampered research in this direction. We demonstrated a strategy, tetramer-guided epitope mapping, that specific CD4+ T cell epitopes can be identified by using PBMC from subjects that have not been exposed to the infectious organism. Sixteen HLA-DR0401- and 14 HLA-DR0701-restricted epitopes within spike protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) were identified. Among these, spike protein residues 159–171, 166–178, 449–461 and 1083–1097 were identified to contain naturally processed immunodominant epitopes based on strong in vitro T cell responses of PBMC (as assayed by tetramer staining) to intact spike protein stimulation. These immunodominant epitopes were confirmed in vivo in HLA-DR0401 transgenic mice by immunizing with spike protein. Furthermore, the epitope-specific T cells from naive donors secreted IFN-γ and IL-13 upon re-stimulation with corresponding tetramers. Our study demonstrates a strategy to determine potential immunodominant epitopes for emerging infectious pathogens prior to their epidemic circulation.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000521 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000521 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:7A829C7ABFA12E0A0EFA5E81E87A85C9C7F396E7
|texte= Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
}}
| This area was generated with Dilib version V0.6.33. |  |